Cargando…
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study
BACKGROUND: Type 2 diabetes (T2D) increases the risk of many types of cancer. Dysregulation of proteasome-related protein degradation leads to tumorigenesis, while Exendin-4, a glucagon-like peptide 1 receptor (GLP-1R) agonist, possesses anti-cancer effects. METHODS: We explored the co-expression of...
Autores principales: | Mao, Dandan, Cao, Huanyi, Shi, Mai, Wang, Chi Chiu, Kwong, Joseph, Li, Joshua Jing Xi, Hou, Yong, Ming, Xing, Lee, Heung Man, Tian, Xiao Yu, Wong, Chun Kwok, Chow, Elaine, Kong, Alice Pik Shan, Lui, Vivian Wai Yan, Chan, Paul Kay Sheung, Chan, Juliana Chung Ngor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938253/ https://www.ncbi.nlm.nih.gov/pubmed/33684886 http://dx.doi.org/10.1016/j.ebiom.2021.103242 |
Ejemplares similares
-
The GLP-1 agonist, exendin-4, stimulates LH secretion in female sheep
por: Simpson, Elizabeth M, et al.
Publicado: (2023) -
Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice
por: He, Lan, et al.
Publicado: (2017) -
Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris
por: Zhou, Jin, et al.
Publicado: (2007) -
Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward
por: Shirazi, Rozita H., et al.
Publicado: (2013) -
Synthesis, Optimization,
and Biological Evaluation
of Corrinated Conjugates of the GLP-1R Agonist Exendin-4
por: Tinsley, Ian C., et al.
Publicado: (2021)